A NEW IDEA ON BIOTECH COMPANY ACORDA ON PATENT INVALIDATION $ACOR $MYL $TEVA
These posts were published on ZYX Short Sell Change Alert. The short zone for Acorda Therapeutics (ACOR) is $24.50 to $26.40. Since the stock is moving fast we want to get this to you quickly. We will do another post shortly with more details. Maximum position size is 30% of full core position size. MORE ON ACOR We have a long history with Acorda Therapeutics (ACOR) from years ago when ACOR started talking about its drug Ampyra, long before the approval of the drug. We have repeatedly been proven right and in the process have made a lot of money. Ampyra is responsible for